RGLS-5579

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameRGLS-5579
Drug Alias NameRGLS-5579
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicroRNA 10b inhibitors
TargetsMicroRNA 10b
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRegulus Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegulus Therapeutics
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A